Are you Dr. Sacks?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 21 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Brigham & Women's Hosp
Boston, MA 02115Phone+1 617-732-6627
Summary
- Dr. David Sacks, MD is a board certified pathologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts and California. He is an Associate Professor at Brigham & Women's Hospital.
Education & Training
- Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 1986 - 1988
- MedStar Health/Georgetown-Washington Hospital CenterFellowship, Hematology and Medical Oncology, 1984 - 1985
- MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1982 - 1984
- District of Columbia General HospitalInternship, Internal Medicine, 1981 - 1982
- University of Cape Town Faculty of MedicineClass of 1976
Certifications & Licensure
- CA State Medical License 1985 - 2026
- MA State Medical License 1980 - 2012
- American Board of Internal Medicine Internal Medicine
- American Board of Pathology Clinical Pathology
Publications & Presentations
PubMed
- 369 citationsGlucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose MonitoringRichard M. Bergenstal, Roy W. Beck, Kelly L. Close, George Grunberger, David B. Sacks
Diabetes Care. 2018-11-01 - 60 citationsThe midgut microbiota plays an essential role in sand fly vector competence for Leishmania majorIsabelle Louradour, Carolina Cunha Monteiro, Ehud Inbar, Kashinath Ghosh, Richard M. Merkhofer
Cellular Microbiology. 2017-06-19 - 258 citationsMolecular aspects of parasite-vector and vector-host interactions in leishmaniasis.David B. Sacks, Shaden Kamhawi
Annual Review of Microbiology. 2001-01-01
Press Mentions
- Leishmania Amazonensis Impairs DC Function by Inhibiting CD40 Expression via A2B Adenosine Receptor ActivationApril 26th, 2012
- Suny Downstate Hematology Oncology FellowshipJune 8th, 2021